Corrigendum to ''Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL ( R) adjuvant'' [Vaccine 20 (2002) 3292-3303]

By Skeiky Y.A.W.   Coler R.N.   Brannon M.   Stromberg E.   Greeson K.   Thomas Crane R.   Webb J.R.   Campos-Neto A.   Reed S.G.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3783-3783

Elsevier

Access to resources Recommend Favorite

The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant

By Scanlen M.   Paweska J.T.   Verschoor J.A.   van Dijk A.A.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1079-1088

Elsevier

Access to resources Recommend Favorite

The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice

By Cataldo D.M.   Van Nest G.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1710-1715

Elsevier

Access to resources Recommend Favorite

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate

By Goetsch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Corvaa N.   Stahl S.   Bonnefoy J.-Y.   Nguyen T.N.   Power U.F.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2735-2742

Elsevier

Access to resources Recommend Favorite

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite